Dong Wen
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-hi Renal Cell Carcinoma (RCC), Adjuvant | Phase 2 | 2025-04-24 |